Links and brief summaries of 7 New HCV and Transplant and/or Treatment Abstracts

[Guest guest]

Transmission of Human Immunodeficiency Virus and Hepatitis C Virus From an Organ

Donor to Four Transplant Recipients (pages 1218–1225)

M. G. Ison, E. Llata, C. S. Conover, J. J. Friedewald, S. I. Gerber, A.

Grigoryan, W. Heneine, J. M. Millis, D. M. Simon, C.-G. Teo and M. J. Kuehnert,

and the HIV-HCV Transplantation Transmission Investigation Team

Article first published online: 6 JUN 2011 | DOI:

10.1111/j.1600-6143.2011.03597.x

The authors present details regarding a case in which HCV and HIV infections

were transmitted from a single donor to multiple recipients. See editorial by

Blumberg on page 1117.

Risk of Window Period Hepatitis-C Infection in High Infectious Risk Donors:

Systematic Review and Meta-Analysis (pages 1188–1200)

L. M. Kucirka, H. Sarathy, P. Govindan, J. H. Wolf, T. A. Ellison, L. J. Hart,

R. A. Montgomery, R. L. Ros and D. L. Segev

Article first published online: 14 MAR 2011 | DOI:

10.1111/j.1600-6143.2011.03460.x

This meta-analysis of HCV incidence among persons in CDC high-risk behavior

categories (originally designed to screen for HIV risk) provides estimates of

the risk of window period HCV infection among potential donors in each behavior

category. See editorial by Pruett on page 1115.

Estimated Risk of Human Immunodeficiency Virus and Hepatitis C Virus Infection

among Potential Organ Donors from 17 Organ Procurement Organizations in the

United States (pages 1201–1208)

K. Ellingson, D. Seem, M. Nowicki, D. M. Strong and M. J. Kuehnert, for the

Organ Procurement Organization Nucleic Acid Testing Yield Project Team

Article first published online: 6 JUN 2011 | DOI:

10.1111/j.1600-6143.2011.03518.x

Results from this study suggest that the risk of undetected HCV infection among

potential organ donors can be significantly reduced by screening with Nucleic

Acid Testing as opposed to serology testing for both normal- and high-risk

donors. See editorial by Pruett on page 1115.

The Impact of IL28B Genetic Variants on Recurrent Hepatitis C in Liver

Transplantation: Significant Lessons from a Dual Graft Case (pages 1325–1329)

T. Motomura, A. Taketomi, T. Fukuhara, Y. Mano, K. Takeishi, T. Toshima, N.

Harada, H. Uchiyama, T. Yoshizumi, Y. Soejima, K. Shirabe, Y. Matsuura and Y.

Maehara

Article first published online: 6 JUN 2011 | DOI:

10.1111/j.1600-6143.2011.03537.x

In this dual graft liver transplantation case, each graft with different IL28B

genotype showed significantly different pathological findings and viral kinetics

after interferon therapy for recurrent hepatitis C.

Haemodynamic derangement in human immunodeficiency virus-infected patients with

hepatitis C virus-related cirrhosis: the role of bacterial translocation (pages

852–860)

Monserrat Montes-de-Oca, - Blanco, Mercedes Marquez, - Soto,

Clotilde Fernandez-Gutiérrez, Claudio -Ramos and A. Giron-

Article first published online: 14 MAR 2011 | DOI:

10.1111/j.1478-3231.2011.02505.x

Anti-ulcer agent teprenone inhibits hepatitis C virus replication: potential

treatment for hepatitis C (pages 873–882)

Masanori Ikeda, Yoshinari Kawai, Kyoko Mori, Masahiko Yano, Ken-ichi Abe, Go

Nishimura, Hiromichi Dansako, Yasuo Ariumi, Takaji Wakita, Kazuhide Yamamoto and

Nobuyuki Kato

Article first published online: 13 MAR 2011 | DOI:

10.1111/j.1478-3231.2011.02499.x